iObserver Version 1.9 Is Released by Caregility: A Continous Virtual Observation & Communications Systems for Monitoring Patients Remotely

November 19, 2020

Caregility, a clinical collaboration and communications company moving the access point of care closer to the patient, announces the release of version 1.9 of its iObserver application, a continuous virtual observation and communications system for remotely monitoring at-risk patients.

iObserver allows clinical teams to remotely observe up to 12 patient rooms on a single screen with two-way audio and video support through the Caregility Platform, a purpose-built, HIPAA-compliant telehealth ecosystem for the entire healthcare continuum.

Caregility leveraged thousands of hours of customer input to build new features and capability into the iObserver v1.9 release. The new version will enhance patient and provider experience and application flexibility with the goals of minimizing adverse events, easing provider burden, and reducing healthcare costs by enabling care teams to do more with less.

Costs associated with the patient sitting are rarely reimbursed and often unbudgeted. With expenses for in-room patient sitters running into the millions, this can have a significant impact on a hospital’s bottom-line and direct care resources.  One Caregility healthcare customer, after deploying iObserver, reported that in eight months of use their unbudgeted sitter hours dropped by 75% with no falls or adverse events.

iObserver enables cost-effective virtual observation across a broad spectrum of use cases, including but not limited to:

  • Clinical deterioration/rapid response events
  • Fall prevention/elopement
  • COVID isolation room – bedside support and room visualization
  • Overflow capacity management
  • Risk to self, from others, or to others

“Caregility is committed to investing in accelerated development that takes into account the experience from both the clinical perspective and the patient perspective,” said Sudhir Ahuja, SVP of Product Development at Caregility. “The iObserver v1.9 release is a great example of taking that input and turning it into a reality for our customers.”

To see a demonstration of how iObserver can help your health system protect patients and drive down costs, as well as unique options we have to help you deal with rising COVID cases with our bedside application that turns any iPad in to a secure communications device in patient rooms, contact Caregility at (732) 440-8040.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version